Results 211 to 220 of about 4,199,505 (352)
Gene screening and immune phenotype shifts of osteoporosis. [PDF]
Hu X, Tian L.
europepmc +1 more source
Schatten class weighted composition operators on generalized Fock spaces F_\phi^2(C^n)
Waleed Al-Rawashdeh
openalex +1 more source
COMPOSITION OPERATORS ACTING ON HILBERT FUNCTION SPACES [PDF]
B. Yousefi, Gh. R. Moghimi
openalex +1 more source
Finite sum of weighted composition operators with closed range
Aboalghasem Alishahi +1 more
openalex +2 more sources
ABSTRACT Objective Glioma recurrence severely impacts patient prognosis, with current treatments showing limited efficacy. Traditional methods struggle to analyze recurrence mechanisms due to challenges in assessing tumor heterogeneity, spatial dynamics, and gene networks.
Lei Qiu +10 more
wiley +1 more source
Identification and characterization of a novel plaque-invisible lytic single-stranded RNA phage. [PDF]
Wang Y +5 more
europepmc +1 more source
CX3CL1 in Early Detection of Alzheimer's Disease: Plasma Dynamics Across Age and Disease Stages
ABSTRACT Backgrounds Alzheimer's disease (AD) is characterized by amyloid‐beta plaques, tau tangles, and neuroinflammation. C‐X3‐C motif chemokine ligand 1 (CX3CL1, also known as fractalkine), a neuroimmune chemokine implicated in AD pathogenesis, shows inconsistent alterations in plasma/serum across studies.
Ling Wang +6 more
wiley +1 more source
Elastosonography in the Differential Diagnosis of Musculoskeletal Soft Tissue Tumors: A Systematic Review. [PDF]
Messina F +10 more
europepmc +1 more source
Functional and Structural Evidence of Neurofluid Circuit Aberrations in Huntington Disease
ABSTRACT Objective Disrupted neurofluid regulation may contribute to neurodegeneration in Huntington disease (HD). Because neurofluid pathways influence waste clearance, inflammation, and the distribution of central nervous system (CNS)–delivered therapeutics, understanding their dysfunction is increasingly important as targeted treatments emerge.
Kilian Hett +8 more
wiley +1 more source

